Clinical Data Inc.

New Life Saving Drugs May Finally Become Affordable, as Clinical Data Inc. Launches a Disruptive Clinical Technology Platform

The cost of new drugs and medical devices is skyrocketing making them unaffordable to many in dire need. Bio-Pharma companies are required to conduct extensive clinical trials; to get their new drugs approved for launch by FDA and other global regulatory agencies. The high cost and risk of conducting clinical trials, are a major driver in making new drugs unaffordable.